61 related articles for article (PubMed ID: 21848946)
1. Assessment of global and regional left ventricular volume and shape by real-time 3-dimensional echocardiography in dogs with myxomatous mitral valve disease.
Ljungvall I; Höglund K; Carnabuci C; Tidholm A; Häggström J
J Vet Intern Med; 2011; 25(5):1036-43. PubMed ID: 21848946
[TBL] [Abstract][Full Text] [Related]
2. Utility of focused cardiac ultrasonography training in veterinary students to differentiate stages of subclinical myxomatous mitral valve disease in dogs.
Huh T; Achilles EJ; Massey LK; Loughran KA; Larouche-Lebel É; Convey V; McKaba VF; Crooks A; Kraus MS; Gelzer AR; Oyama MA
J Vet Intern Med; 2024; 38(3):1325-1333. PubMed ID: 38532734
[TBL] [Abstract][Full Text] [Related]
3. Current use of real-time three-dimensional transthoracic echocardiography in animals.
Tidholm A; Menciotti G; Borgarelli M
J Vet Cardiol; 2024 Feb; 51():97-104. PubMed ID: 38118235
[TBL] [Abstract][Full Text] [Related]
4. Iron parameters analysis in dogs with myxomatous mitral valve disease.
Kumiega E; A Kobak K; Noszczyk-Nowak A; Kasztura M
BMC Vet Res; 2024 May; 20(1):210. PubMed ID: 38762716
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a mitral regurgitation severity index to predict long-term outcome in dogs with myxomatous mitral valve disease.
Vereb M; Atkins CE; Adin D; Blondel T; Coffman M; Lee S; Guillot E; Ward JL
J Vet Intern Med; 2024; 38(1):51-60. PubMed ID: 37909399
[TBL] [Abstract][Full Text] [Related]
6. Mitral annular disjunction and myxomatous mitral valve disease in a dog.
Pereira N
J Vet Cardiol; 2024 Feb; 51():9-12. PubMed ID: 37989026
[TBL] [Abstract][Full Text] [Related]
7. RNA sequencing provides novel insights into the pathogenesis of naturally occurring myxomatous mitral valve disease stage B1 in beagle dogs.
Kim TS; Hong CY; Oh SJ; Choe YH; Hwang TS; Kim J; Lee SL; Yoon H; Bok EY; Cho AR; Do YJ; Kim E
PLoS One; 2024; 19(5):e0300813. PubMed ID: 38753730
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease.
Galizzi A; Bagardi M; Stranieri A; Zanaboni AM; Malchiodi D; Borromeo V; Brambilla PG; Locatelli C
BMC Vet Res; 2021 Jan; 17(1):15. PubMed ID: 33413406
[TBL] [Abstract][Full Text] [Related]
9. Interventricular inflow time difference assessed by dual pulsed-wave Doppler echocardiography in dogs with myxomatous mitral valve disease.
Morita T; Nakamura K; Osuga T; Kawamoto S; Takiguchi M
J Vet Cardiol; 2024 Feb; 51():24-34. PubMed ID: 38071798
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation, echocardiographic findings, treatment strategies, and prognosis of dogs with myxomatous mitral valve disease presented with pericardial effusion due to suspected left atrial tear: a retrospective case-control study.
Czech AA; Glaus TM; Testa F; Romito G; Baron Toaldo M
J Vet Cardiol; 2024 Feb; 51():105-115. PubMed ID: 38128416
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-lymphocyte ratio is increased in dogs with acute congestive heart failure secondary to myxomatous mitral valve disease compared to both dogs with heart murmurs and healthy controls.
DeProspero DJ; Hess RS; Silverstein DC
J Am Vet Med Assoc; 2023 Nov; 261(11):1-8. PubMed ID: 37406992
[TBL] [Abstract][Full Text] [Related]
12. Myxomatous mitral valve disease and associated pulmonary hypertension might increase serum angiopoietin-2 in dogs.
Yu H; Lee D; Chae Y; Choi M; Lee Y; Yun T; Kang BT; Yang MP; Kim H
Am J Vet Res; 2024 Jun; 85(6):. PubMed ID: 38531156
[TBL] [Abstract][Full Text] [Related]
13. Association between echocardiographic indexes and urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) in dogs with myxomatous mitral valve disease.
Crosara S; Fidanzio F; Oricco S; Dondi F; Mazzoldi C; Monari E; Romito G; Sabetti MC; Troìa R; Quintavalla C
Res Vet Sci; 2024 May; 171():105211. PubMed ID: 38458044
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of serum ionized magnesium concentration in dogs with myxomatous mitral valve disease.
Kim OK; Kim K; Park S; Yang H; Kim H; Ro WB; Lee CM
J Vet Intern Med; 2024; 38(1):41-50. PubMed ID: 38064361
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Right Ventricular Tei Index in Dogs with Myxomatous Mitral Valvular Heart Disease.
Nakamura K; Morita T; Osuga T; Morishita K; Sasaki N; Ohta H; Takiguchi M
J Vet Intern Med; 2016; 30(1):69-75. PubMed ID: 26789419
[TBL] [Abstract][Full Text] [Related]
16. Effects of mitral valve repair on valvular geometry and hemodynamics in dogs with myxomatous mitral valve disease.
Mihara K; Kanemoto I; Sato K; Yasuhira Y; Watanabe I; Suzuki Y; Nagura J; Misumi K
Vet Surg; 2024 Apr; 53(3):415-425. PubMed ID: 38205863
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic predictors of positive left ventricular remodeling in patients with a history of active myocarditis.
Kozieł-Siołkowska M; Boidol J; Miszalski-Jamka K; Kalarus Z; Kukulski T
Pol Arch Intern Med; 2024 Feb; 134(2):. PubMed ID: 38166567
[TBL] [Abstract][Full Text] [Related]
18. Myxomatous mitral valve disease in dogs: does size matter?
Parker HG; Kilroy-Glynn P
J Vet Cardiol; 2012 Mar; 14(1):19-29. PubMed ID: 22356836
[TBL] [Abstract][Full Text] [Related]
19. Platelet proteome changes in dogs with congestive heart failure.
Levent P; Kocaturk M; Akgun E; Saril A; Cevik O; Baykal AT; Tanaka R; Ceron JJ; Yilmaz Z
BMC Vet Res; 2020 Nov; 16(1):466. PubMed ID: 33256720
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of the serum in dogs with pulmonary hypertension secondary to myxomatous mitral valve disease: the preliminary study.
Sakarin S; Rungsipipat A; Roytrakul S; Jaresitthikunchai J; Phaonakrop N; Charoenlappanit S; Thaisakun S; Surachetpong SD
Front Vet Sci; 2024; 11():1327453. PubMed ID: 38596466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
